Clinical Trial Update: Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease [Phase 2, Phase 3]

View source ↗

Summary

This document provides a clinical trial update on varying doses of ticagrelor and their effects on platelet aggregation and endothelial function in diabetic pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: UNKNOWN